Skip to Content

MYLAN 8008 MYLAN 8008 (Divalproex sodium delayed-release (sprinkle) 125 mg)

This pill with imprint "MYLAN 8008 MYLAN 8008" is Purple / White, Capsule-shape and has been identified as Divalproex sodium delayed-release (sprinkle) 125 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MYLAN 8008 MYLAN 8008

Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008
Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008
Divalproex sodium delayed-release (sprinkle) 125 mg MYLAN 8008 MYLAN 8008

Divalproex sodium delayed-release (sprinkle)

Imprint:
MYLAN 8008 MYLAN 8008
Strength:
125 mg
Color:
Purple / White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-8008

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide